About The Author

Editorial & Columns

A Brief History of Drug Price Control in India  

December 11, 2024 | Dr. Anil Kumar Angrish | No Comments |

More

Editorial & Columns

AI-focused Partnerships of Global Pharmaceutical Companies

December 5, 2024 | Dr. Anil Kumar Angrish | No Comments |

More

Editorial & Columns

Indian Pharmaceutical Industry in Consolidation Mode

November 27, 2024 | Dr. Anil Kumar Angrish | No Comments |

More

Editorial & Columns

Cultivating Intrapreneurship: Lessons from Leading Pharmaceutical Companies

November 21, 2024 | Dr. Anil Kumar Angrish | No Comments |

More

Editorial & Columns

Monitoring Prices, Availability, Accessibility & Affordability of Medicines-Role of PMRUs

November 14, 2024 | Dr. Anil Kumar Angrish | No Comments |

More

Editorial & Columns

Pharmapreneurs in India and their Career Transition

November 6, 2024 | Dr. Anil Kumar Angrish | No Comments |

More

Editorial & Columns

FY24 Review: Intellectual Capital of Top Indian Pharmaceutical Companies

October 28, 2024 | Dr. Anil Kumar Angrish | No Comments |

More

Editorial & Columns

Pay Gap in Indian Pharmaceutical Industry: Remuneration of Managerial Personnel vis-à-vis Employees

October 23, 2024 | Dr. Anil Kumar Angrish | No Comments |

More

Editorial & Columns

Employment Dynamics in Indian Pharmaceutical Industry

October 16, 2024 | Dr. Anil Kumar Angrish | No Comments |

More

Potpourri

Obituary: Ratan Naval Tata

October 10, 2024 | Dr. Anil Kumar Angrish | No Comments |

More